OPTN and amyotrophic lateral sclerosis: Two ALS-associated mutations in OPTN have been found to likely affect its ubiquitin-binding ability either indirectly through changes to the dimeric structure of OPTN or directly through mutations in the ubiquitin-binding domain (Li et al., 2018).